← Back to Search

Other

nPEP (non-invasive positive expiratory pressure) mask for Tracheobronchomalacia

N/A
Waitlist Available
Led By Loretta G Que, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, two weeks
Awards & highlights

Study Summary

This trial will test if a device that helps you breathe out can reduce coughing, help you breathe better, and improve quality of life for people with TBM who can't have stenting.

Eligible Conditions
  • Tracheobronchomalacia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, two weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, two weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Cough Severity as Measured by the Cough Visual Analog Scale (VAS)
Change in Quality of Life as Measured by the Cough-Specific Quality-of-Life Questionnaire (CQLQ)
Change in Quality of Life as Measured by the Leicester Cough Questionnaire (LCQ)
Secondary outcome measures
Proximal Airway Reactance at 5 Hz (X5) as Assessed by Impulse Oscillometry

Trial Design

1Treatment groups
Experimental Treatment
Group I: nPEP RecipientsExperimental Treatment1 Intervention
Single-patient, adjustable expiratory resistance device that provides positive pressure (5 to 20 cm H2O) during expiration
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
nPEP (non-invasive positive expiratory pressure) mask
2021
N/A
~10

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,358 Previous Clinical Trials
3,420,059 Total Patients Enrolled
Loretta G Que, MDPrincipal InvestigatorDuke University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Apr 2025